Drugs Home > Canakinumab
Canakinumab is licensed to treat certain types of rare genetic conditions called cryopyrin-associated periodic syndromes. It can also be used to treat a certain type of juvenile arthritis. This prescription medication comes in the form of an injection that is given just under the skin once every eight weeks. Potential side effects include diarrhea, nausea, and symptoms of the common cold.
What Is Canakinumab?
- Rare genetic autoinflammatory conditions known as cryopyrin-associated periodic syndromes (CAPS), such as:
- Familial cold autoinflammatory syndrome (FCAS)
- Muckle-Wells syndrome (MWS)
- Systemic juvenile idiopathic arthritis (SJIA).